Document is current
Any future updates will be listed below
-
Authors
Yan, Ziyi
Fu, Yunhan
Tan, Xi
Xu, Ling
Ling, Jiaji
Liu, Xinxing
Miao, Chenglin
Liu, Li
Cui, Yali
Li, Hong
Kuang, Linghan
Jiang, Yongmei
-
Funding
Funding for this research was provided by:
National Natural Science Foundation of China (82300015)
Sichuan Science and Technology Program (2024NSFSC1555, 2024NSFSC1942, 2024YFFK0350, 2022YFS0235, 2023NSFSC1699, 2023YFS0222)
- License Information
-
More Information
Article History
Received: 29 July 2024
Accepted: 9 September 2024
First Online: 14 September 2024
Declarations
:
: The clinical experimental plan was approved by the Clinical Trial Ethics Committee of West China Second University Hospital, Sichuan University (No. 2023 − 290). Informed consent for adult participation was waived by the Clinical Trial Ethics Committee of West China Second University Hospital, Sichuan University, according to the Chinese government “Measures for the Ethical Review of Life Science and Medical Research Involving Human Beings” (Chapter III, Article 32, ). For minors, informed consent was obtained from legal guardians on behalf of the minors involved in the study. The work was carried out in accordance with the Declaration of Helsinki.
: Not applicable.
: The authors declare no competing interests.
